Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGLT-2 inhibitor for postoperative hyperglycemia in acute abdominal surgery
NCT05314725Phase 2Unknown
- Sponsor
- Zealand University Hospital
- Start
- Jun 2022
- Primary completion
- May 2023
01
Overview
Phase 2, randomised, double-blind trial in hyperglycemia (2 arms), sponsored by Zealand University Hospital. Primary endpoint: Time in Range at 10 days. Status: unknown.
02
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT05314725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05314725.